ZYDUS WELLNESS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2024 ,inter alia, to consider and approve Unaudited Financial Results for the ...

Ahmedabad: Zydus Lifesciences Limited has received tentative approval from the United States Food and Drug Administration (USFDA) to manufacture Enzalutamide Tablets, 40 mg and 80 mg (USRLD: Xtandi ...

Zydus Wellness, an Indian FMCG company, has expanded its Complan brand into the adult nutrition market with the launch of VieMax. Announced today, this move marks the brand’s first venture into ...

Work with your peers to hone your skills, and put them to use right away. Engage stakeholders through managerial and soft skills Build an M&E plan Design empirical project evaluation Evaluate impact ...

Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Enzalutamide Capsules, 40 mg (USRLD: Xtandi Capsules, 40 mg ...

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Enzalutamide Capsules, 40 mg (USRLD: Xtandi Capsules, 40 mg). Enzalutamide ...

Zydus Lifesciences receives USFDA approval to manufacture Enzalutamide capsules (40 mg), a generic prostate cancer treatment drug. The drug will be produced at the company's Moraiya, Ahmedabad ...

As per the agreement, CDRI and Zydus will jointly undertake preclinical research, it said. Any drug candidate emerging from the efforts will be developed by Zydus for India and other markets, it added ...

It has initiated will a 'sell' ratings on Dr Reddys', Lupin Zydus Lifesciences and Auro Pharma with target price of Rs 5,700, Rs 2,250, Rs 850 and Rs 1,333, respectively, suggesting a downside of ...

UBS mentioned that trends are weakening in both India and the US. UBS has initiated coverage on Zydus Lifesciences Ltd. and Dr Reddy's Laboratories Ltd. with a 'Sell' recommendation, setting price ...